Version history
OncoStart
18
ASO score
Text
21/100
Reviews
0/100
Graphic
40/100
Other
0/100
App Rating
Votes
App Age
3y 9m
Last Update
Jul 15, 2025
Compare with Category Top Apps
|
Metrics
|
Current App
|
Category Top Average
|
Difference
|
|---|---|---|---|
|
Installs
|
10
|
2.3M
|
-100%
|
|
Rating
|
0
|
4.16
|
|
|
Number of Ratings (Voted)
|
0
|
2.5M
|
|
|
App Age
|
3y 9m
|
7y 8m
|
-52%
|
|
In-app Purchases Price
|
$0
|
$47
|
|
|
Update Frequency
|
166d
|
172d
|
-4%
|
|
Title Length
|
9
|
25
|
-64%
|
|
Short Description Length
|
28
|
63
|
-56%
|
|
Description Length
|
233
|
2 677
|
-91%
|
|
Number of Screenshots
|
1072
|
1275
|
-16
%
|
|
Has Video?
|
No
|
0% has videos
|
|
|
Size
|
0MB
|
0MB
|
|
Category Ranking in United States
7 days
Last 7 days
Last 30 days
Last 90 days
Last 180 days
Last year
| Top | Dec 21, 2025 | Dec 28, 2025 |
|---|---|---|
|
No results were found!
|
||
| Top | Dec 21, 2025 | Dec 28, 2025 |
|---|---|---|
|
No results were found!
|
||
| Top | Dec 21, 2025 | Dec 28, 2025 |
|---|---|---|
|
No results were found!
|
||
| Top | Dec 21, 2025 | Dec 28, 2025 |
|---|---|---|
|
No results were found!
|
||
Downloads
Downloads Graph
Total
9
Last month
1
Text ASO
Title
(
Characters:
9
of 50
)
OncoStart
Short Description
(
Characters:
28
of 80
)
OncoStart Mobile application
Description
(
Characters:
233
of 4000
)
Mobile Application will be installed by the HCPs, This mobile App will generate the Patient onboarding steps according to each patient profile, New tab for DLBCL included Epcoritamab dosing and premedication to prevent CRS and ICANS.}
Other
Additional Information
| Rating: | |
| Voted: | 0 |
| Google Play Link: | |
| Website: | - |
| Email: | - |
| Privacy Policy: | |
| Categories: | Medical |
| Size: | - |
| Installs: | 9 |
| App Age: | 3 years 9 months |
| Release Date: | Apr 04, 2022 |
| Last Update: | Jul 15, 2025 |
| Version: | 2.5.0 |
Version history
2.5.0
Jul 15, 2025
New tab for DLBCL included Epcoritamab dosing and premedication to prevent CRS and ICANS.
2.4.0
Sep 27, 2024
New tab for DLBCL included Epcoritamab dosing and premedication to prevent CRS and ICANS.
